Drugs for Osteoarthritis Pain Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Osteoarthritis Pain Market Perspective (2017-2028)
2.2 Drugs for Osteoarthritis Pain Growth Trends by Region
2.2.1 Drugs for Osteoarthritis Pain Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Drugs for Osteoarthritis Pain Historic Market Size by Region (2017-2022)
2.2.3 Drugs for Osteoarthritis Pain Forecasted Market Size by Region (2023-2028)
2.3 Drugs for Osteoarthritis Pain Market Dynamics
2.3.1 Drugs for Osteoarthritis Pain Industry Trends
2.3.2 Drugs for Osteoarthritis Pain Market Drivers
2.3.3 Drugs for Osteoarthritis Pain Market Challenges
2.3.4 Drugs for Osteoarthritis Pain Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue
3.1.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue (2017-2022)
3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2017-2022)
3.2 Global Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Osteoarthritis Pain Revenue
3.4 Global Drugs for Osteoarthritis Pain Market Concentration Ratio
3.4.1 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Osteoarthritis Pain Revenue in 2021
3.5 Drugs for Osteoarthritis Pain Key Players Head office and Area Served
3.6 Key Players Drugs for Osteoarthritis Pain Product Solution and Service
3.7 Date of Enter into Drugs for Osteoarthritis Pain Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Osteoarthritis Pain Breakdown Data by Type
4.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Type (2017-2022)
4.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2023-2028)
5 Drugs for Osteoarthritis Pain Breakdown Data by Application
5.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Application (2017-2022)
5.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Drugs for Osteoarthritis Pain Market Size (2017-2028)
6.2 North America Drugs for Osteoarthritis Pain Market Size by Type
6.2.1 North America Drugs for Osteoarthritis Pain Market Size by Type (2017-2022)
6.2.2 North America Drugs for Osteoarthritis Pain Market Size by Type (2023-2028)
6.2.3 North America Drugs for Osteoarthritis Pain Market Share by Type (2017-2028)
6.3 North America Drugs for Osteoarthritis Pain Market Size by Application
6.3.1 North America Drugs for Osteoarthritis Pain Market Size by Application (2017-2022)
6.3.2 North America Drugs for Osteoarthritis Pain Market Size by Application (2023-2028)
6.3.3 North America Drugs for Osteoarthritis Pain Market Share by Application (2017-2028)
6.4 North America Drugs for Osteoarthritis Pain Market Size by Country
6.4.1 North America Drugs for Osteoarthritis Pain Market Size by Country (2017-2022)
6.4.2 North America Drugs for Osteoarthritis Pain Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Drugs for Osteoarthritis Pain Market Size (2017-2028)
7.2 Europe Drugs for Osteoarthritis Pain Market Size by Type
7.2.1 Europe Drugs for Osteoarthritis Pain Market Size by Type (2017-2022)
7.2.2 Europe Drugs for Osteoarthritis Pain Market Size by Type (2023-2028)
7.2.3 Europe Drugs for Osteoarthritis Pain Market Share by Type (2017-2028)
7.3 Europe Drugs for Osteoarthritis Pain Market Size by Application
7.3.1 Europe Drugs for Osteoarthritis Pain Market Size by Application (2017-2022)
7.3.2 Europe Drugs for Osteoarthritis Pain Market Size by Application (2023-2028)
7.3.3 Europe Drugs for Osteoarthritis Pain Market Share by Application (2017-2028)
7.4 Europe Drugs for Osteoarthritis Pain Market Size by Country
7.4.1 Europe Drugs for Osteoarthritis Pain Market Size by Country (2017-2022)
7.4.2 Europe Drugs for Osteoarthritis Pain Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size (2017-2028)
8.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Type
8.2.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Share by Type (2017-2028)
8.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Application
8.3.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Share by Application (2017-2028)
8.4 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region
8.4.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drugs for Osteoarthritis Pain Market Size (2017-2028)
9.2 Latin America Drugs for Osteoarthritis Pain Market Size by Type
9.2.1 Latin America Drugs for Osteoarthritis Pain Market Size by Type (2017-2022)
9.2.2 Latin America Drugs for Osteoarthritis Pain Market Size by Type (2023-2028)
9.2.3 Latin America Drugs for Osteoarthritis Pain Market Share by Type (2017-2028)
9.3 Latin America Drugs for Osteoarthritis Pain Market Size by Application
9.3.1 Latin America Drugs for Osteoarthritis Pain Market Size by Application (2017-2022)
9.3.2 Latin America Drugs for Osteoarthritis Pain Market Size by Application (2023-2028)
9.3.3 Latin America Drugs for Osteoarthritis Pain Market Share by Application (2017-2028)
9.4 Latin America Drugs for Osteoarthritis Pain Market Size by Country
9.4.1 Latin America Drugs for Osteoarthritis Pain Market Size by Country (2017-2022)
9.4.2 Latin America Drugs for Osteoarthritis Pain Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size (2017-2028)
10.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type
10.2.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Type (2017-2028)
10.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application
10.3.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Application (2017-2028)
10.4 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country
10.4.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Drugs for Osteoarthritis Pain Introduction
11.1.4 Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Introduction
11.2.4 Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.2.5 Johnson & Johnson Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Introduction
11.3.4 GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.3.5 GlaxoSmithKline Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Drugs for Osteoarthritis Pain Introduction
11.4.4 Bayer Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.4.5 Bayer Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Introduction
11.5.4 Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.5.5 Eli Lilly Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Drugs for Osteoarthritis Pain Introduction
11.6.4 Novartis Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.6.5 Novartis Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Drugs for Osteoarthritis Pain Introduction
11.7.4 Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.7.5 Sanofi Recent Developments
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Details
11.8.2 Horizon Pharma Business Overview
11.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Introduction
11.8.4 Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.8.5 Horizon Pharma Recent Developments
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Drugs for Osteoarthritis Pain Introduction
11.9.4 Abbott Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.9.5 Abbott Recent Developments
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Drugs for Osteoarthritis Pain Introduction
11.10.4 Mylan Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.10.5 Mylan Recent Developments
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Details
11.11.2 Daiichi Sankyo Business Overview
11.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Introduction
11.11.4 Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.11.5 Daiichi Sankyo Recent Developments
11.12 TEVA
11.12.1 TEVA Company Details
11.12.2 TEVA Business Overview
11.12.3 TEVA Drugs for Osteoarthritis Pain Introduction
11.12.4 TEVA Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.12.5 TEVA Recent Developments
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Details
11.13.2 Almatica Pharma Business Overview
11.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Introduction
11.13.4 Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.13.5 Almatica Pharma Recent Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Details
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Introduction
11.14.4 Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.14.5 Astellas Pharma Recent Developments
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Details
11.15.2 Tide Pharmaceutical Business Overview
11.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Introduction
11.15.4 Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.15.5 Tide Pharmaceutical Recent Developments
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Details
11.16.2 Iroko Pharmaceuticals Business Overview
11.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Introduction
11.16.4 Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.16.5 Iroko Pharmaceuticals Recent Developments
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Details
11.17.2 Hengrui Pharmaceutical Business Overview
11.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Introduction
11.17.4 Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.17.5 Hengrui Pharmaceutical Recent Developments
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Details
11.18.2 Abiogen Pharma Business Overview
11.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Introduction
11.18.4 Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.18.5 Abiogen Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of External
Table 5. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Drugs for Osteoarthritis Pain Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Drugs for Osteoarthritis Pain Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Drugs for Osteoarthritis Pain Market Share by Region (2017-2022)
Table 9. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Drugs for Osteoarthritis Pain Market Share by Region (2023-2028)
Table 11. Drugs for Osteoarthritis Pain Market Trends
Table 12. Drugs for Osteoarthritis Pain Market Drivers
Table 13. Drugs for Osteoarthritis Pain Market Challenges
Table 14. Drugs for Osteoarthritis Pain Market Restraints
Table 15. Global Drugs for Osteoarthritis Pain Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Drugs for Osteoarthritis Pain Revenue Share by Players (2017-2022)
Table 17. Global Top Drugs for Osteoarthritis Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2021)
Table 18. Ranking of Global Top Drugs for Osteoarthritis Pain Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Drugs for Osteoarthritis Pain Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Drugs for Osteoarthritis Pain Product Solution and Service
Table 22. Date of Enter into Drugs for Osteoarthritis Pain Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drugs for Osteoarthritis Pain Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2017-2022)
Table 26. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2023-2028)
Table 28. Global Drugs for Osteoarthritis Pain Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Drugs for Osteoarthritis Pain Revenue Share by Application (2017-2022)
Table 30. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Drugs for Osteoarthritis Pain Revenue Share by Application (2023-2028)
Table 32. North America Drugs for Osteoarthritis Pain Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Drugs for Osteoarthritis Pain Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Drugs for Osteoarthritis Pain Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Drugs for Osteoarthritis Pain Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Drugs for Osteoarthritis Pain Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Drugs for Osteoarthritis Pain Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Drugs for Osteoarthritis Pain Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Drugs for Osteoarthritis Pain Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Drugs for Osteoarthritis Pain Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Drugs for Osteoarthritis Pain Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Drugs for Osteoarthritis Pain Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Drugs for Osteoarthritis Pain Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Drugs for Osteoarthritis Pain Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Drugs for Osteoarthritis Pain Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Drugs for Osteoarthritis Pain Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Drugs for Osteoarthritis Pain Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Drugs for Osteoarthritis Pain Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Drugs for Osteoarthritis Pain Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Drugs for Osteoarthritis Pain Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Drugs for Osteoarthritis Pain Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Drugs for Osteoarthritis Pain Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Drugs for Osteoarthritis Pain Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Drugs for Osteoarthritis Pain Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Drugs for Osteoarthritis Pain Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Drugs for Osteoarthritis Pain Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Drugs for Osteoarthritis Pain Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Drugs for Osteoarthritis Pain Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Drugs for Osteoarthritis Pain Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Drugs for Osteoarthritis Pain Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Drugs for Osteoarthritis Pain Market Size by Country (2023-2028) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Drugs for Osteoarthritis Pain Product
Table 65. Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 66. Pfizer Recent Developments
Table 67. Johnson & Johnson Company Details
Table 68. Johnson & Johnson Business Overview
Table 69. Johnson & Johnson Drugs for Osteoarthritis Pain Product
Table 70. Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 71. Johnson & Johnson Recent Developments
Table 72. GlaxoSmithKline Company Details
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Drugs for Osteoarthritis Pain Product
Table 75. GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 76. GlaxoSmithKline Recent Developments
Table 77. Bayer Company Details
Table 78. Bayer Business Overview
Table 79. Bayer Drugs for Osteoarthritis Pain Product
Table 80. Bayer Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 81. Bayer Recent Developments
Table 82. Eli Lilly Company Details
Table 83. Eli Lilly Business Overview
Table 84. Eli Lilly Drugs for Osteoarthritis Pain Product
Table 85. Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 86. Eli Lilly Recent Developments
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Drugs for Osteoarthritis Pain Product
Table 90. Novartis Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 91. Novartis Recent Developments
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Drugs for Osteoarthritis Pain Product
Table 95. Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 96. Sanofi Recent Developments
Table 97. Horizon Pharma Company Details
Table 98. Horizon Pharma Business Overview
Table 99. Horizon Pharma Drugs for Osteoarthritis Pain Product
Table 100. Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 101. Horizon Pharma Recent Developments
Table 102. Abbott Company Details
Table 103. Abbott Business Overview
Table 104. Abbott Drugs for Osteoarthritis Pain Product
Table 105. Abbott Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 106. Abbott Recent Developments
Table 107. Mylan Company Details
Table 108. Mylan Business Overview
Table 109. Mylan Drugs for Osteoarthritis Pain Product
Table 110. Mylan Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 111. Mylan Recent Developments
Table 112. Daiichi Sankyo Company Details
Table 113. Daiichi Sankyo Business Overview
Table 114. Daiichi Sankyo Drugs for Osteoarthritis Pain Product
Table 115. Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 116. Daiichi Sankyo Recent Developments
Table 117. TEVA Company Details
Table 118. TEVA Business Overview
Table 119. TEVA Drugs for Osteoarthritis Pain Product
Table 120. TEVA Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 121. TEVA Recent Developments
Table 122. Almatica Pharma Company Details
Table 123. Almatica Pharma Business Overview
Table 124. Almatica Pharma Drugs for Osteoarthritis Pain Product
Table 125. Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 126. Almatica Pharma Recent Developments
Table 127. Astellas Pharma Company Details
Table 128. Astellas Pharma Business Overview
Table 129. Astellas Pharma Drugs for Osteoarthritis Pain Product
Table 130. Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 131. Astellas Pharma Recent Developments
Table 132. Tide Pharmaceutical Company Details
Table 133. Tide Pharmaceutical Business Overview
Table 134. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 135. Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 136. Tide Pharmaceutical Recent Developments
Table 137. Iroko Pharmaceuticals Company Details
Table 138. Iroko Pharmaceuticals Business Overview
Table 139. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product
Table 140. Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 141. Iroko Pharmaceuticals Recent Developments
Table 142. Hengrui Pharmaceutical Company Details
Table 143. Hengrui Pharmaceutical Business Overview
Table 144. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 145. Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 146. Hengrui Pharmaceutical Recent Developments
Table 147. Abiogen Pharma Company Details
Table 148. Abiogen Pharma Business Overview
Table 149. Abiogen Pharma Drugs for Osteoarthritis Pain Product
Table 150. Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 151. Abiogen Pharma Recent Developments
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Osteoarthritis Pain Market Share by Type: 2021 VS 2028
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. External Features
Figure 5. Global Drugs for Osteoarthritis Pain Market Share by Application: 2021 VS 2028
Figure 6. Medical Care Case Studies
Figure 7. Personal Care Case Studies
Figure 8. Drugs for Osteoarthritis Pain Report Years Considered
Figure 9. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Drugs for Osteoarthritis Pain Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Drugs for Osteoarthritis Pain Market Share by Region: 2021 VS 2028
Figure 12. Global Drugs for Osteoarthritis Pain Market Share by Players in 2021
Figure 13. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2021
Figure 15. North America Drugs for Osteoarthritis Pain Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Drugs for Osteoarthritis Pain Market Size Market Share by Type (2017-2028)
Figure 17. North America Drugs for Osteoarthritis Pain Market Size Market Share by Application (2017-2028)
Figure 18. North America Drugs for Osteoarthritis Pain Market Size Share by Country (2017-2028)
Figure 19. United States Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Drugs for Osteoarthritis Pain Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Type (2017-2028)
Figure 23. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Application (2017-2028)
Figure 24. Europe Drugs for Osteoarthritis Pain Market Size Share by Country (2017-2028)
Figure 25. Germany Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Drugs for Osteoarthritis Pain Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Drugs for Osteoarthritis Pain Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Drugs for Osteoarthritis Pain Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Drugs for Osteoarthritis Pain Market Size Share by Region (2017-2028)
Figure 35. China Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Drugs for Osteoarthritis Pain Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Drugs for Osteoarthritis Pain Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Drugs for Osteoarthritis Pain Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Drugs for Osteoarthritis Pain Market Size Share by Country (2017-2028)
Figure 45. Mexico Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Drugs for Osteoarthritis Pain Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Drugs for Osteoarthritis Pain Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Drugs for Osteoarthritis Pain Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Drugs for Osteoarthritis Pain Market Size Share by Country (2017-2028)
Figure 51. Turkey Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Pfizer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 55. Johnson & Johnson Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 57. Bayer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 58. Eli Lilly Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 59. Novartis Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 60. Sanofi Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 61. Horizon Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 62. Abbott Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 63. Mylan Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 64. Daiichi Sankyo Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 65. TEVA Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 66. Almatica Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 67. Astellas Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 68. Tide Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 69. Iroko Pharmaceuticals Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 70. Hengrui Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 71. Abiogen Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Industry Market Size
